During the past decade, Centrum Alergologii Teresa Hofman Sp. z o.o. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centrum Alergologii Teresa Hofman Sp. z o.o." are "Allergic Rhinitis Due to Dermatophagoides Farinae" (1 trials), "Allergic Rhinitis Due to Dermatophagoides Pteronyssinus" (1 trials), "Allergic Rhinitis Due to House Dust Mite" (1 trials) and "Chronic Cough" (1 trials). Many other conditions were trialed in "Centrum Alergologii Teresa Hofman Sp. z o.o." in a lesser frequency.

Most popular intervention types in "Centrum Alergologii Teresa Hofman Sp. z o.o." are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Placebo to S-600918" (1 trials), "S-600918" (1 trials) and "Sublingual allergy immunotherapy tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Alergologii Teresa Hofman Sp. z o.o." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centrum Alergologii Teresa Hofman Sp. z o.o.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centrum Alergologii Teresa Hofman Sp. z o.o., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Alergologii Teresa Hofman Sp. z o.o., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".